Kikuchi S - Search Results

1

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.

Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Waraya M, Kawamata H, Nishimiya H, Nakamura K, Watanabe M. Ooki A, et al. Among authors: kikuchi s. BMC Cancer. 2011 Apr 6;11:122. doi: 10.1186/1471-2407-11-122. BMC Cancer. 2011. PMID: 21466710 Free PMC article.

2

Clinical significance of total gastrectomy for proximal gastric cancer.

Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Hutawatari N, Watanabe M. Ooki A, et al. Among authors: kikuchi s. Anticancer Res. 2008 Sep-Oct;28(5B):2875-83. Anticancer Res. 2008. PMID: 19031928 Free article.

3

Strong association of lymph node metastasis with intraperitoneal free cancer cell (IFCC) in advanced gastric cancer.

Yamashita K, Sakuramoto S, Kikuchi S, Katada N, Kobayashi N, Watanabe M. Yamashita K, et al. Among authors: kikuchi s. Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1873-7. Hepatogastroenterology. 2008. PMID: 19102412

4

Phosphatase of regenerating liver-3 as a prognostic biomarker in histologically node-negative gastric cancer.

Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Watanabe M. Ooki A, et al. Among authors: kikuchi s. Oncol Rep. 2009 Jun;21(6):1467-75. doi: 10.3892/or_00000376. Oncol Rep. 2009. PMID: 19424625

5

Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.

Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Watanabe M. Ooki A, et al. Among authors: kikuchi s. Int J Cancer. 2010 Aug 1;127(3):543-54. doi: 10.1002/ijc.25082. Int J Cancer. 2010. PMID: 19960436

6

Prognostic impact of venous invasion in stage IB node-negative gastric cancer.

Araki I, Hosoda K, Yamashita K, Katada N, Sakuramoto S, Moriya H, Mieno H, Ema A, Kikuchi S, Mikami T, Watanabe M. Araki I, et al. Among authors: kikuchi s. Gastric Cancer. 2015 Apr;18(2):297-305. doi: 10.1007/s10120-014-0362-2. Epub 2014 Apr 1. Gastric Cancer. 2015. PMID: 24687437

7

Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.

Ema A, Yamashita K, Ushiku H, Kojo K, Minatani N, Kikuchi M, Mieno H, Moriya H, Hosoda K, Katada N, Kikuchi S, Watanabe M. Ema A, et al. Among authors: kikuchi m, kikuchi s. Cancer Sci. 2014 Dec;105(12):1591-600. doi: 10.1111/cas.12556. Epub 2014 Dec 3. Cancer Sci. 2014. PMID: 25455899 Free PMC article.

8

Survival outcome of Borrmann type IV gastric cancer potentially improved by multimodality treatment.

Yamashita K, Hosoda K, Katada N, Moriya H, Mieno H, Higuchi K, Sasaki T, Katada C, Sakuramoto S, Tanabe S, Koizumi W, Kikuchi S, Watanabe M. Yamashita K, et al. Among authors: kikuchi s. Anticancer Res. 2015 Feb;35(2):897-906. Anticancer Res. 2015. PMID: 25667472

9

Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy.

Ema A, Yamashita K, Sakuramoto S, Wang G, Mieno H, Nemoto M, Shibata T, Katada N, Kikuchi S, Watanabe M. Ema A, et al. Among authors: kikuchi s. Gastric Cancer. 2014 Jan;17(1):67-75. doi: 10.1007/s10120-013-0253-y. Epub 2013 Jun 26. Gastric Cancer. 2014. PMID: 23801337 Clinical Trial.

10

Clinical evaluation of pN-stage (TNM) in gastric cancer: an analysis of distribution of regional lymph nodes in node-positive patients.

Kikuchi S, Nemoto Y, Katada N, Sakuramoto S, Kobayashi N, Shimao H, Sakakibara Y, Kakita A. Kikuchi S, et al. Anticancer Res. 2002 Mar-Apr;22(2B):1141-4. Anticancer Res. 2002. PMID: 12168914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,562 results

Search Page

Filters